123 related articles for article (PubMed ID: 31303650)
1. Agressive NK-cell leukemia in a pediatric patient.
Rey-Helo E; Pérez-Velásquez RD; Cortés-Alva D
Bol Med Hosp Infant Mex; 2019; 76(4):188-192. PubMed ID: 31303650
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
3. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
4. [Aggressive NK-cell leukemia with sustained relapse-free survival after allogeneic peripheral blood stem cell transplantation].
Ino K; Masuya M; Nakamori Y; Suzuki K; Mizutani M; Sekine T; Yamaguchi M; Nakase K; Kaida K; Ogawa H; Katayama N
Rinsho Ketsueki; 2010 Apr; 51(4):258-63. PubMed ID: 20467222
[TBL] [Abstract][Full Text] [Related]
5. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias.
Cheung MM; Chan JK; Wong KF
Semin Hematol; 2003 Jul; 40(3):221-32. PubMed ID: 12876671
[TBL] [Abstract][Full Text] [Related]
8. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
9. Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Ichikawa S; Fukuhara N; Yamamoto J; Suzuki M; Nakajima S; Okitsu Y; Kohata K; Onishi Y; Ishizawa K; Kameoka J; Harigae H
Intern Med; 2010; 49(17):1907-10. PubMed ID: 20823655
[TBL] [Abstract][Full Text] [Related]
10. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative disorders of natural killer cells.
Oshimi K
Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
[TBL] [Abstract][Full Text] [Related]
12. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
[TBL] [Abstract][Full Text] [Related]
13. Aggressive natural killer (NK) cell lymphoma: report of a pediatric case and review of the literature.
Ohnuma K; Toyoda Y; Nishihira H; Iguchi A; Honda K; Nagao T; Kigasawa H; Tanaka Y; Kikuta H
Leuk Lymphoma; 1997 Apr; 25(3-4):387-92. PubMed ID: 9168449
[TBL] [Abstract][Full Text] [Related]
14. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
15. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
16. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
[TBL] [Abstract][Full Text] [Related]
18. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
[TBL] [Abstract][Full Text] [Related]
19. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
[TBL] [Abstract][Full Text] [Related]
20. [Iatrogenic immunodeficiency-associated Epstein-Barr virus (EBV) -negative natural killer cell lymphoproliferative disorder in a patient undergoing rheumatoid arthritis therapy].
Uchida T; Inoue M; Hua J; Tajima S; Ota Y; Hagihara M
Rinsho Ketsueki; 2017; 58(6):624-629. PubMed ID: 28679993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
